D
SpringWorks Therapeutics, Inc. SWTX
$46.80 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 4.80% 18.05% 32.61% 48.77% -19.02%
Total Depreciation and Amortization 51.03% 89.03% 77.73% 120.94% 188.14%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 16.25% 2.71% 15.84% 17.01% 27.76%
Change in Net Operating Assets 1.74% 404.27% -130.07% -676.75% -77.52%
Cash from Operations 12.89% 52.95% 49.71% 12.59% -27.68%
Capital Expenditure 94.80% -145.70% 49.01% 68.43% 80.62%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 233.14% 109.41% -20.21% -98.02% -78.30%
Cash from Investing 241.95% 108.88% -17.20% -99.52% -78.23%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -61.98% -99.61% 8,036.36% 42,800.00% 7,062.65%
Repurchase of Common Stock -98.08% -106.72% -89.02% -161.08% -236.46%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -1,821.92% -99.78% 633.47% 1,085.67% 70.13%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 89.70% -119.05% 128.32% -402.55% -266.06%